
Vaccines for the Prevention of Cervical Cancer
Oxford University Press
Published on 19. November 2009
Book
Paperback/Softback
176 pages
978-0-19-958863-3 (ISBN)
Description
Cervical cancer is the second most common form of cancer found in women and is responsible for more than a quarter of a million deaths worldwide each year. With approximately 70% of cervical cancers now known to be caused by two oncogenic types of the human papillomavirus (HPV), there is great interest surrounding the approval of the vaccine for clinical use. Despite this, many questions remain about how the new vaccines should be implemented and how cervical cancer screening will change following vaccination.
This practical pocketbook provides an overview of the role of HPV in the pathophysiology of cervical cancer and its current screening and management, the principles of immune control of HPV infection in cervical cancer, and the challenges of implementing HPV vaccines and future developments. This revised edition includes updated trial data in the chapter on prophylactic HPV vaccination: current status.
This practical pocketbook provides an overview of the role of HPV in the pathophysiology of cervical cancer and its current screening and management, the principles of immune control of HPV infection in cervical cancer, and the challenges of implementing HPV vaccines and future developments. This revised edition includes updated trial data in the chapter on prophylactic HPV vaccination: current status.
More details
Series
Edition
Revised edition
Language
English
Place of publication
Oxford
United Kingdom
Target group
Professional and scholarly
Edition type
Revised edition
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 178 mm
Width: 99 mm
Thickness: 10 mm
Weight
136 gr
ISBN-13
978-0-19-958863-3 (9780199588633)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Peter L. Stern is Professor of Immunology, Patterson Institute of Cancer Research, Christie Hospital NHS Trust, University of Manchester, Manchester, UK
Henry C. Kitchener is Professor of Gynacological Oncology at St. Mary's Hospital, University of Manchester, manchester, UK
Henry C. Kitchener is Professor of Gynacological Oncology at St. Mary's Hospital, University of Manchester, manchester, UK
Editor
UK Immunology Group, Paterson Institute for Cancer Research, University of Manchester, UK
Gynaecological Oncology, St Mary's Hospital, University of Manchester, UK
Content
1. The UK cervical screening programme ; 2. Management of cervical intraepithelial neoplasia (CIN) ; 3. Role of HPV in cervical carcinogenesis ; 4. HPV and genital cancer: the essential epidemiology ; 5. The role of HPV testing in cervical screening ; 6. Natural immune control of HPV infection ; 7. Prophylactic HPV vaccines: pre-clinical and proof of principle studies ; 8. Prophylactic HPV vaccination: current status ; 9. Introduction of HPV prophylactic vaccination ; 10. HPV vaccination in the developing world ; 11. Screening post vaccination ; 12. Second-generation HPV prophylactic vaccines ; 13. Therapeutic HPV vaccines ; 14. Conclusion